Biomarkers will be used in the new guidelines for Crohn’s disease.

The American Gastroenterological Association put out new practice rules on how to use biomarkers to help treat Crohn’s disease. The guidelines are made up of 11 conditional suggestions that are meant to help doctors use common biomarkers found in feces and blood, such as fecal protein and C-reactive protein, to track the disease’s activity over time and from one time point to another in people with Crohn’s disease.

Pratima Dibba, MD, a clinical teacher at the NYU Grossman School of Medicine and a board-certified gastroenterologist who works at Medical Offices of Manhattan, remarked on the usefulness of the recommendations. Read the article.